Steven Pipe, MD, defines Hemophilia B and its standard of care.
Examining Evolving Treatment Paradigms in the Hemophilia B Space
Dr Steven Pipe delves into the economic burden associated with Hemophilia B treatment, including costs and payer considerations.
A hematologic expert explains the role gene therapy might play with Hemophilia B.
Dr Pipe discusses the impact of gene therapy in the Hemophilia B landscape, for both the payer and patient.
Steven Pipe, MD, describes his hopes for Hemophilia B treatment in the future.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
What IRA drug prices will mean for PBMs, health plans and patients
2
Catheter ablation shows benefits for patients with both aFib and sleep apnea
3
Ultra-processed foods linked to early-onset colorectal adenomas in women
4
Biosimilar competition could surpass IRA-negotiated savings by year three
5
